Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with asymptomatic castrate-resistant prostate cancer with bone metastases who have not received any bisphosphonates in the 12 months prior to enrollment
18 years old and over
You may not be if
Plan to be on cytotoxic or biologic therapy during study
Active dental problems
Active heart complications
Active infection
Patients with moderate to severe swelling due to fluid
Clareo Health | A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases
